A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device
|
|||||
       
 |
A company developing a needle patch for vaccine delivery is acquiring the rights to a synthetic SARS-Cov-2 spike protein for its Covid-19 vaccine patch. . . . → Read More: Univ. Lab Licenses Protein for Vaccine Patch  Comments are closed  Intellectual property, New products  biomedical, biotechnology, chemistry, clinical trials, Covid-19, engineering, licensing, life sciences, medical device, pharmaceuticals, physical sciences, preclinical, university 
A biotechnology company discovering protein therapies in fungi is collaborating with drug maker GlaxoSmithKline to find new small molecule drugs. . . . → Read More: Drug Discovery Biotech Inks Partnering Deal, Gains $175M 3 comments - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A biotechnology enterprise plans to discover synthetic antibodies with 3-D printed lymph node tissue for future licensing to a pharma company. . . . → Read More: Synthetic Antibodies to be Designed with Organoids 
A U.S. patent appeals board ruled that the Broad Institute at Harvard and MIT is the discoverer of Crispr gene editing techniques in animal cells. . . . → Read More: Patent Board Rules for Broad Inst. in Crispr Case One comment - (Comments are closed) Intellectual property biomedical, biotechnology, chemistry, Europe, genomics, life sciences, patent, physical sciences, university, USPTO 
A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue. . . . → Read More: Pharma Company Licenses Protein Delivery Hydrogel Comments are closed Intellectual property, New products Asia, biomedical, chemistry, engineering, India, licensing, life sciences, materials science, pharmaceuticals, physical sciences, university 
A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure. . . . → Read More: University Lab Licenses Printed Kidney Tissue Process One comment - (Comments are closed) Intellectual property, New products biomedical, biotechnology, engineering, entrepreneurs, licensing, life sciences, materials science, medical device, physical sciences, stem cells, university 
A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion. . . . → Read More: Biotech Partners on Gene Editing Tech in $1.35B Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, genomics, licensing, life sciences, nanotechnology, pharmaceuticals 
A company analyzing public health data by geography and social factors received a patent for its system identifying likely opioid addiction hot spots. . . . → Read More: Patent Awarded for Opioid Risk System with Geographic Data Comments are closed Intellectual property, New products biomedical, blockchain, computer science, economics, engineering, entrepreneurs, health care, mathematics, patent, physical sciences, software, USPTO 
A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion. . . . → Read More: Regeneron Gains Cancer, Infectious Disease Immunotherapies Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, Covid-19, equity, Europe, investment, licensing, life sciences, pharmaceuticals |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
